Study explorer (study characteristics and results) method abbreviations

display ongoing studies
Study studied treatmentcontrol treatmentpatientsrisk of biassample sizes Results

COVID-19 severe or critically meta-analysis

ARI-RAF (Della-Torre), 2020OBSsarilumabcontrolCOVID-19 severe or criticallyNA
28/28 inconclusive
    no demonstrated benefit a

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);